Welcome to our dedicated page for Sensient Tech SEC filings (Ticker: SXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sensient Technologies Corporation filings document the regulatory record of a Wisconsin-based operating company that manufactures and markets colors, flavors, and other specialty ingredients. Form 8-K disclosures cover quarterly and annual results of operations, financial condition, Regulation FD investor presentations, and exhibits tied to earnings releases for the company's ingredient segments.
Governance filings include the definitive proxy statement, annual meeting voting results, director elections, advisory executive-compensation votes, auditor ratification, and board committee and bylaw changes. Other current reports document executive and segment-leadership matters within the Color and Flavors & Extracts groups, along with formal exhibits and corporate-governance updates.
Sensient Technologies Corp. (SXT) filed a Form 4 on 1 July 2025 reporting that director Dr. Mario Ferruzzi acquired 55.116 deferred stock units on 30 June 2025 through the company’s Directors’ Deferred Compensation Plan. Each unit is economically equivalent to one share of common stock and will be issued when the director leaves the board. After this routine award, Ferruzzi’s holdings consist of 7,980.067 common shares held directly, 225.529 shares held indirectly via his spouse’s ESOP account, and 3,103.917 deferred stock units. No common shares were sold, and the transaction involved no cash outlay because it reflects a deferral of board fees rather than an open-market purchase.
Form 4 filing overview – Sensient Technologies Corp. (SXT)
Director Deborah McKeithan-Gebhardt reported a routine change to her equity position on 30 June 2025. The transaction involved the acquisition of 83.054 deferred stock units under the company’s Directors’ Deferred Compensation Plan. These units convert to common stock on a one-for-one basis and will be issued when the director’s board service ends.
Following the transaction, McKeithan-Gebhardt’s total beneficial ownership stands at 16,280.531 shares of common stock held directly and 5,468.395 deferred stock units, for an aggregated exposure of roughly 21,749 shares. No common shares were bought or sold in the open market, and no cash consideration was exchanged; the additional units reflect fee deferral rather than a discretionary share purchase.
The filing does not disclose any option grants, sales, or derivative disposals, and there are no indications of material changes to the insider’s overall ownership percentage or to the company’s capital structure. Given the small size of the award (≈0.002% of SXT’s ~45 million shares outstanding), the transaction is considered routine and non-material from a liquidity or control standpoint. However, the directionally positive addition may still be interpreted by some investors as a signal of ongoing board alignment with shareholder interests.